Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
, edema of caruncle, conjunctival hyperemia, chemosis, could be considered, if based on comparison with a color picture atlas, as objective manifestations and, therefore, be included in the CRO. In other words, a new 5-item Clinical Activity Score (CAS
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Search for other papers by Kenneth Ka Hei Lai in
Google Scholar
PubMed
Department of Ophthalmology, Salmaniya Medical Complex, Government Hospitals, Bahrain
Search for other papers by Fatema Mohamed Ali Abdulla Aljufairi in
Google Scholar
PubMed
Department of Ophthalmology, Vicente Sotto Memorial Medical Center, Cebu City, Philippines
Search for other papers by Jake Uy Sebastian in
Google Scholar
PubMed
Search for other papers by Yingying Wei in
Google Scholar
PubMed
Search for other papers by Ruofan Jia in
Google Scholar
PubMed
Search for other papers by Karen Kar Wun Chan in
Google Scholar
PubMed
Search for other papers by Elaine Yuen Ling Au in
Google Scholar
PubMed
Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Search for other papers by Chiu Ming Ng in
Google Scholar
PubMed
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Hunter Kwok Lai Yuen in
Google Scholar
PubMed
Search for other papers by Wilson Wai Kuen Yip in
Google Scholar
PubMed
Search for other papers by Alvin Lerrmann Young in
Google Scholar
PubMed
Search for other papers by George Pak Man Cheng in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Clement Chee Yung Tham in
Google Scholar
PubMed
Search for other papers by Chi Pui Pang in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Kelvin Kam Lung Chong in
Google Scholar
PubMed
followed up for at least 12 months. Outcome measures Clinical Activity Score (CAS) was used to assess the disease activity clinically ( 18 ). Gorman diplopia score was used to score diplopia: 1, no diplopia; 2, gaze-evoked diplopia; 3, intermittent
Department of Women’s and Children’s Health, Pediatric Endocrinology Unit, Padua University Hospital, Padua, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Cristina Clausi in
Google Scholar
PubMed
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Search for other papers by Yi Hang Zhu in
Google Scholar
PubMed
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Search for other papers by Maria Chiara Pedron in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Giulia Midena in
Google Scholar
PubMed
Search for other papers by Raffaele Parrozzani in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
TED into mild, moderate-to-severe and sight-threatening. The most recent EUGOGO guidelines confirm the clinical activity score (CAS), proposed by Mourits et al. ( 9 ), as the best-validated scoring system for evaluating disease activity ( 7 ). TED is
Department of Ophthalmology, University Hospital Essen, Essen, Germany
Search for other papers by Nora Dehina in
Google Scholar
PubMed
Search for other papers by Peter Josef Hofmann in
Google Scholar
PubMed
Search for other papers by Thomas Behrends in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Search for other papers by Lutz Schomburg in
Google Scholar
PubMed
-1860). The diagnosis of GO as well as the TRAK and IGF1R-aAB measurements have been described earlier [ 5 , 8 ]. The clinical activity score (CAS) and the severity of eye changes (NOSPECS) were determined according to previously published classification
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Search for other papers by Özgür Demir in
Google Scholar
PubMed
Search for other papers by Reyhan Ünlü Ersoy in
Google Scholar
PubMed
Search for other papers by Kamile Gül in
Google Scholar
PubMed
Search for other papers by Berna İmge Aydoğan in
Google Scholar
PubMed
Search for other papers by Ziynet Alphan Üç in
Google Scholar
PubMed
Search for other papers by Türkan Mete in
Google Scholar
PubMed
Search for other papers by Sibel Ertek in
Google Scholar
PubMed
Search for other papers by Uğur Ünlütürk in
Google Scholar
PubMed
Search for other papers by Bekir Çakır in
Google Scholar
PubMed
Search for other papers by Yalçın Aral in
Google Scholar
PubMed
Search for other papers by Serdar Güler in
Google Scholar
PubMed
Search for other papers by Sevim Güllü in
Google Scholar
PubMed
Search for other papers by Demet Çorapçıoğlu in
Google Scholar
PubMed
Search for other papers by Selçuk Dağdelen in
Google Scholar
PubMed
Search for other papers by Gürbüz Erdoğan in
Google Scholar
PubMed
developed in the last 6 months 2 Thyroid volume ≥15 ml 3 No previous treatment except local interventions for GO 4 GO activity defined as clinical activity score (CAS) ≥3 and carrying at least one of the following criteria: proptosis ≥21 mm in one
Search for other papers by Elena Sabini in
Google Scholar
PubMed
Search for other papers by Ilaria Ionni in
Google Scholar
PubMed
Search for other papers by Roberto Rocchi in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
had a lagophthalmos in the right eye, a clinical activity score according to Mourits et al. [ 11 ] of 3/7 points (with mild palpebral edema, conjunctival redness, and chemosis, only in the right eye), a normal visual acuity, and a reduction of motility
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
fortification of salt. J Clin Endocrinol Metab 2012;97:2325-2332. 10.1210/jc.2012-1275 22518849 10 Mourits MP, Prummel MF, Wiersinga WM, Koornneef L: Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin
Search for other papers by Sofie Jespersen in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Lars Østergaard Kristensen in
Google Scholar
PubMed
cessation of treatment (see below). The results were collected in January 2015. The patients were diagnosed with hyperthyroidism and GO with a clinical activity score ≥4 [ 7 ]. None of the patients had previously been treated with glucocorticoids. None of
Search for other papers by Elena Sabini in
Google Scholar
PubMed
Search for other papers by Marenza Leo in
Google Scholar
PubMed
Search for other papers by Barbara Mazzi in
Google Scholar
PubMed
Search for other papers by Roberto Rocchi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Marco Nardi in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
total of 99 consecutive patients seen in our GO Clinic between 2010 and 2014 were enrolled. All patients underwent an ophthalmological examination, which included: (i) exophthalmometry; (ii) evaluation of the clinical activity score (CAS) according to
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Michel Depierreux in
Google Scholar
PubMed
Search for other papers by Elçin Ozalp in
Google Scholar
PubMed
Search for other papers by Brigitte Velkeniers in
Google Scholar
PubMed
corticosteroids, the lymph nodes decreased in size and the orbitopathy clinical activity score improved, with a significant decrease in inflammatory disease demonstrated by MRI. Nevertheless, the firm thyroid enlargement persisted. Case Report A 50-year